Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

MITOXANTRONE HYDROCHLORIDE

MITOXANTRONE HYDROCHLORIDE

Standard Dose
EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MITOXANTRONE HYDROCHLORIDE is listed in Drugs@FDA under application 078606 (ANDA).

Marketing status: Discontinued Active ingredient MITOXANTRONE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) Sponsor FRESENIUS KABI ONCOL Submission history Latest submission status date: 2008-05-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview MITOXANTRONE HYDROCHLORIDE is listed in Drugs@FDA under application 078606 (ANDA). Marketing status: Discontinued Active ingredient MITOXANTRONE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) Sponsor FRESENIUS KABI ONCOL Submission history Latest submission status date: 2008-05-14 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.